| Product Code: ETC6184982 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s metal stents market is expanding due to rising incidences of cardiovascular diseases and the aging population. Demand is growing for both bare-metal stents and drug-eluting variants. Supportive government healthcare programs and advancements in minimally invasive surgical procedures are further propelling market growth.
The metal stents market in Australia is experiencing consistent growth due to the aging population and the increasing incidence of cardiovascular diseases. Technological advancements such as drug-eluting stents, biodegradable stents with metal backbones, and minimally invasive procedures are driving demand. The healthcare sectors emphasis on better patient outcomes and fast recovery is encouraging hospitals to adopt newer, high-performance stent technologies.
The metal stents market in Australia faces significant regulatory hurdles, as all medical devices must go through extensive testing and approval from health authorities like the TGA (Therapeutic Goods Administration). Cost pressures from both private and public healthcare providers demand more affordable stent solutions, which may compromise innovation. Additionally, growing preference for bioresorbable stents poses competition to traditional metal stents.
The growing demand for cardiovascular treatments in Australia presents robust investment opportunities in the metal stents market. Investors can partner with medical technology companies or establish local manufacturing units focused on high-performance stents like drug-eluting or bioresorbable stents. Regulatory support for innovation and a well-developed healthcare system make Australia an ideal base for R&D centers and clinical trials for next-gen vascular implants.
In the metal stents market, government policies are heavily influenced by health regulations and the approval process for medical devices. The Therapeutic Goods Administration (TGA) is the primary regulatory body, ensuring that metal stents meet rigorous safety and efficacy standards before they can be sold in Australia. Policies around reimbursement through the Medicare system also play a significant role, determining which stents are included for funding and affecting their adoption in clinical settings. Additionally, the Australian government supports innovation in the medical device industry through grants and incentives for research and development in advanced stent technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Metal Stents Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Metal Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Metal Stents Market - Industry Life Cycle |
3.4 Australia Metal Stents Market - Porter's Five Forces |
3.5 Australia Metal Stents Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Metal Stents Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Australia Metal Stents Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Metal Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases requiring stent placement |
4.2.2 Technological advancements leading to the development of innovative metal stents |
4.2.3 Rising adoption of minimally invasive procedures in Australia |
4.3 Market Restraints |
4.3.1 High cost associated with metal stents impacting adoption rates |
4.3.2 Complications and risks associated with metal stent placement procedures |
5 Australia Metal Stents Market Trends |
6 Australia Metal Stents Market, By Types |
6.1 Australia Metal Stents Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Metal Stents Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Metal Stents Market Revenues & Volume, By Coronary Stents, 2021- 2031F |
6.1.4 Australia Metal Stents Market Revenues & Volume, By Peripheral Vascular Stents, 2021- 2031F |
6.2 Australia Metal Stents Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Australia Metal Stents Market Revenues & Volume, By Bare Metal, 2021- 2031F |
6.2.3 Australia Metal Stents Market Revenues & Volume, By Drug Eluting, 2021- 2031F |
6.2.4 Australia Metal Stents Market Revenues & Volume, By Bioreabsorbable, 2021- 2031F |
6.3 Australia Metal Stents Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Metal Stents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Metal Stents Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
6.3.4 Australia Metal Stents Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Metal Stents Market Import-Export Trade Statistics |
7.1 Australia Metal Stents Market Export to Major Countries |
7.2 Australia Metal Stents Market Imports from Major Countries |
8 Australia Metal Stents Market Key Performance Indicators |
8.1 Average procedure time for metal stent placement |
8.2 Number of research and development investments in metal stent technologies |
8.3 Rate of adoption of metal stents in new clinical applications |
9 Australia Metal Stents Market - Opportunity Assessment |
9.1 Australia Metal Stents Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Metal Stents Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Australia Metal Stents Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Metal Stents Market - Competitive Landscape |
10.1 Australia Metal Stents Market Revenue Share, By Companies, 2024 |
10.2 Australia Metal Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here